chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ASSESSMENT AND PLAN: 1. Moderate persistent asthma, unspecified whether complicated (Primary) Assessment & Plan: Unfortunately she has been taking albuterol bid to tid and no flovent and noting wheezing. Now knows to take flovent bid and albuterol as needed. Discussed the rule of 2s. Resent 1 albuterol with 1 refill. This should last 6-12 months if well controlled. Will restart same dose of flovent and will f/u in 1 -2 months. If still wheezing or feeling like lung control is not ideal then would increase flovent dose. Will monitor. Return precautions discussed    Orders: -     fluticasone (FLOVENT DISKUS) 100 MCG/BLIST diskus inhaler; Inhale 1 puff into the lungs 2 times daily.  Dispense: 60 each; Refill: 5 -     albuterol 90 mcg/puff inhaler; Inhale 2 puffs into the lungs every 4 hours as needed for Wheezing, Shortness of Breath or Increased Work of Breathing (RESCUE).  Dispense: 8.5 g; Refill: 1   2. Nausea after vaccination Comments: start zofran as needed for n/v related to covid 19 vaccination. will monitor. push fluids. get rest.  Orders: -     ondansetron (ZOFRAN ODT) 4 mg disintegrating tablet; Take 1 tablet by mouth every 8 hours as needed for Nausea.  Dispense: 24 tablet; Refill: 0
patient developed generalized urticarial rash the day after she took the covid-19 (moderna) vaccination.
Client presented at a HCF vaccination site on 01/18/22. The client reported he received his Janssen COIVD vaccine on 06/23/21. Client reported after seven to eight hours after vaccination, he had shortness of breath (SOB) with lightheadedness for 5 minutes. Client reported he did deep breath, and the SOB went away. Client reported he did not follow-up with his PCP. Client told he has no chronic illnesses, not taking any medications, nor has any known allergy. Client is requesting booster dose of Pfizer COVID vaccine today. PHN submitted a medical consult via text message to clinical project coordinator requesting to proceed with the booster dose of Pfizer COVID vaccine. Per the doctor, approval to proceed with the booster dose of Pfizer COVID vaccine was obtained via text message from clinical project coordinator. Client received the booster dose of Pfizer COVID vaccine, LOT#: FL3209 on 01/18/22 at 1737 by LVN. The client did not report any symptoms during the 30-minute observation period. PHN educated client on possible adverse reactions and when to seek EMS. Client verbalized understanding. Client left vaccination site at 1807 unassisted and with a steady gait.
Patient initially developed fever 14 days after administration of vaccine. He was then fever free for 24 hours, but then developed additional fever on 11/21 that led to three generalized seizures (complex febrile seizure) requiring multiple doses of ativan as well as keppra load and then maintenance keppra. He required admission to the hospital for further monitoring and observation. He returned to baseline within 24 hours and did not have any additional seizures within that 24 hour observation period. He will continue on maintenance keppra until follow up with neurology.
Patient seen at clinic, reported to have "rash" on her upper arm, at site of injection. When seen rash noted to have primary raised welt surrounded by slightly lighter red flush redness. Patient was assessed by primary care physicians. Dr. prescribed a topical steroid and also an antibiotic.
Patient was a 10 year old Male that administered one dose of Pfizer Pediatric (0.2mL) at 1645 on 11/19/2021 at Vaccination Clinic. After roughly a few minutes, he began to exhibit signs that were seen to be a possible allergic reaction. He began to state that he was experiencing shortness of breath. Nurses assessed the patient and began initiating emergency care on the patient. At about 1654, 911 was called and Fire Department Paramedics arrived on scene at 1703. After careful assessment by both nurses and Paramedics, the patients was ruled out as not experiencing an allergic reaction. The patient was  thought to have been suffering from anxiety, with no severe complications. No medication was administered and patient was directed to stay in Observation Area longer for safety. Patient's condition began to improve and he went home with his father.
The patient was given 0.25mL of the Moderna Spikevax vaccine intended for patients ages 12 and older. No adverse reactions.
Very deep coughs; trouble sleeping at night; This is a spontaneous report from a Pfizer sponsored program. A non-contactable consumer reported for a female patient (reporter's wife) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: not reported), via an unspecified route of administration on an unspecified date as unknown, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced very deep coughs and had trouble sleeping at night. The outcome of events was unknown.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021680667 Same reporter/drug/AE, different patient
11 days after second dose, Thursday, April 29, I had light menstrual spotting. Toilet paper would be pink after wiping and spots on Poise pad in underwear. I have been in menopause for 3 years. By Saturday June 1 I do not notice any further spotting.
Three days after vaccine so weak I had to follow pt around. He was afraid of falling. By May 2nd, he could not stand up and needing a wheel chair. Went to the ER on the 10th. They only admitted after his o2 fell and could not get It under control.
Pt. c/o nausea, feeling flushed, and swelling of both hands approximately 1 hour after receiving FluMist vaccine.
Pneumonia RA-Redness from RA to R elbow, felt hot, minimal amount of swelling. At 17:00, it got hotter and took Benadryl and applied ice pack and it felt better but area remained hot and about the same amount of swelling. The next day, it started itching. Took Benadryl before bed, the night before and took Benadryl and Tylenol about 2 days. Mid-day, the heat was less but redness remained. The swelling took about 4 days to go down. Redness stayed until the 5th day. By the 5th day, stopped Benadryl and Tylenol and then it gradually went away.
I was at work and feeling sluggish and couldn't hardly breathe. I went to the hospital and was told my kidneys were failing and my blood pressure was dropping lower and lower. My kidneys were dehydrated and I needed to get fluids.
after my vaccine I started spotting. In the 3 years I had the MIRENA IUD, I did not have spotting or a period once.; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: was not reported, Expiry date: unknown, at the age of 34 years), dose 1 via an unspecified route of administration on 21May2021 11:30 as dose 1, single for covid-19 immunisation. Medical history included MIRENA IUD from an unspecified date in 2018 (I had a MIRENA IUD at time of my vaccination (since 2018) - after my vaccine I started spotting) and MIRENA IUD removed (I had my MIRENA IUD removed 18Jun2021). The concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient reported after her vaccine she started spotting. In the 3 years she had the Mirena iud, she did not have spotting or a period once. The spotting began after her first vaccine dose and the spotting has continued since then. The patient underwent lab tests and procedures which included blood test: normal (Her ob/gyn administered a blood test and the results came back normal, she was concerned the vaccine has affected her cycle) on an unspecified date, sars-cov-2 test: negative on 21May2021. The patient did not receive any treatment for the event. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The reporter assessed the events as non-serious. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
No adverse events took place, but I am submitting this VAERS because the patient received a Moderna shot and she is outside of the specified age requirements.  The pharmacist on duty was giving her a flu shot, when the mother mentioned that the patient is to receive her first COVID vaccine the following week. The pharmacist said, "we can give her the covid vaccine now along  with the flu shot." He proceeded to do so without regard to the vaccine age requirements. The mother asked if the vaccine being administered is the children's Pfizer, and he told her it is moderna. She asked if it is ok for her to get the moderna vaccine and he said yes. I came into work the following day and was notified by another employee that a child had received a moderna the previous day, so I contacted the NMDOH and informed them what happened, next I spoke with the child's mother and asked how her child is doing and was informed that she is doing well with no adverse effects.
covid arm started after about 1 week from the patient's first shot. she has redness, swelling, pain, itchiness at the place of the injection. Also, the area is a bit heard and all this started after 1 week from her first shot. It has been for 3 days so far! She also has noticed a swollen lymph node by the neck area , at the same side of the injection, it's about 1 inch length. Also this was noticed after 5 to 6 ay from the first shot.  it has been three days so far and it is still there it is a bit harder now compare to what it feels when first appeared.
Long Haul Syndrome; Depressing/turned off; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A 63-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, Manufacturer Unknown), for COVID-19 immunization. The following information was reported: POST-ACUTE COVID-19 SYNDROME (non-serious), outcome "unknown", described as "Long Haul Syndrome"; DEPRESSION (non-serious), outcome "unknown", described as "Depressing/turned off".  Additional information: The reporter stated depressing turned off, it immediately reminded what the patient went through after booster shot and the patient is still suffering and struggling with Long Haul Syndrome. The reporter stated that it immediately became obvious to her the first teenager she saw already seemingly looked depressed; which in turn brought memories to her about when she took the vaccination and all that she had endured from that.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient phoned in to let us know they had vomiting episodes on the second day after their vaccine.
patient called friday 11/26 concerned about redness/slight swelling and warmth , some itch at site of vaccine on wednesday.  advised patient on taking tylenol for pain or ibuprofen for the swelling, also to take benedryl to help with swelling and possible itch.  advised to watch closely and even page her primary doctor before monday if condition worsened.    called patient today 11/29 to see how she was.  she said area is redder and slightly tingling.  her daughter is a nurse and looked at area over weekend and thinks may be infected.  patient has schedule appointment with dr for tomorrow 11/30 at 2:30pm to check.
This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a adult female patient who received BOOSTRIX for wound. Co-suspect products included DTaP vaccine. In 2014, the patient received BOOSTRIX and DTAP vaccine. In 2014, an unknown time after receiving BOOSTRIX and DTAP vaccine, the patient experienced extra dose administered. On an unknown date, the patient experienced bedridden, appetite lost, generalised joint pain and fever. On an unknown date, the outcome of the extra dose administered, bedridden, appetite lost, generalised joint pain and fever were unknown. The reporter considered the extra dose administered, bedridden, appetite lost, generalised joint pain and fever to be almost certainly related to BOOSTRIX and DTAP vaccine. Additional information received: In 2014, the patient received a dose of Tdap (unknown name). Then, 6 months later, the patient received a BOOSTRIX dose for a wound she had, that led to an extra dose administered. She also experienced adverse events: bedridden, appetite lost, generalised joint pain and fever. The nurse which is the patient reported to the sales representative that she was almost certain the issues were from the BOOSTRIX, but was unsure if it was from the combination of both products.
This case was reported by a healthcare professional and described the occurrence of inappropriate dose of vaccine administered in an adult female subject who was vaccinated with Fluarix, GlaxoSmithKline for prophylaxis.  On 12 November 2007 at 12:00 the subject received an unspecified dose of Fluarix (unknown, left arm).  The subject experienced inappropriate dose of vaccine administered and accidental exposure as part of the dose ran down the subject's arm during the injection, and pharmaceutical product complaint.  The nurse reported that she believed that the needle may have become loose when she removed the needle cover prior to the injection causing part of the dose to leak out during the injection.  She was using a Luer-lok needle with the pre-filled syringe.  There were no clinical events reported but the nurse is concerned that the subject may not be protected with only the partial dose.  She plans to repeat the dose.  At the time of reporting the outcome of the pharmaceutical product complaint was unspecified.
chest pain; This is a spontaneous report from a non-contactable consumer (patient). This male patient of unspecified age received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had an appointment for the second dose of the Pfizer COVID-19 vaccine tomorrow (11May2021) but had to go to the hospital today (10May2021) because he had chest pain. The patient wanted to know if he could reschedule his appointment and get the vaccine today. The outcome of chest pain was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a 12 month old white male patient with otitis media and upper respiratory tract infection who on 12/12/04 was vaccinated SC with a dose of MMR. Secondary concomitant vaccination on 12/12/04 included a dose of varicella virus vaccine live, diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid, influenza virus vaccine, HIB conjugate vaccine. Concomitant medication included prednisolone Na phosphate and budesonide. On 12/12/04, the patient experienced fever (from 101-103.7 degrees F), foam at mouth, 6 areas of redness and boil left thigh. The patient came to the office on 12/14/04 and was treated with cephalexin. On 12/17/04 the patient experienced foamy loose stool. On 12/20/04 the patient experienced roseola described as a rash all over. It was reported that the patient had recovered from the roseola, the boil, the areas of redness, the fever, and the foamy loose stools and the foaming at the mouth. Additional information is not expected.
Vaccine was SHINGRIX. I did not feel well. I felt light headed, dizzy like vertigo and I had light colored stools for a week.
The day after I got the vaccine, I had extreme headache, sore arm, and fever of 38.5 degree Celsius. I decided to take cold-warm shower, and Metamizole 1mg. The fever went down a couple of hours after. I continued with the medication the next day for the headache. At night of the next day, I had nausea. Three days after the shot, I have not taken any more medications, no more fever, sore arm, nor nausea, but still have a mild headache.
Post vax, the pt experienced a period of closing eyes, rolling back her head as if looking at the ceiling and apparent loss of balance. This occurred approximately eight times. It looked like she lost control of her head. These movements did not occur while sitting. The pt was brought to the ER. The pt's mother declined any lab testing.
Erythema Multiforme Major - Severe rash on right inner thigh and pubic region .
Per mother, patient became unconsolable,refused to eat within 24 hr. after the vaccine. No report of an elevated temperature. This continued for over 24 hr.,for which patient was refered to the ER for further evaluation.Resolved within 48 hrs.
watery eyes,  dizziness, headache  BP 140/61 HR 90 Pulse ox 96%on RA
Adverse reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No relevant concomitant medications reported No relevant medical history was reported.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse reactions). At the time of the report, VACCINATION COMPLICATION (Adverse reactions) outcome was unknown.            patient is taking two courses of steroids.
pt came in today as an acute for macular papular eruption;pt recv vax 14AUG98 & devel erythema & a rash around site of inj;intermittent papules, occasionally pustules that burst;cough;not feeling wonderfully;itchy;erythematous dry papules;
Shaking chills onset 12 hours after the vaccine, followed by fever to 101.6, sore throat, dry cough, headache, nasal congestion, muscle aches, and fatigue at 24 hours post-injection. The fever and other symptoms subsided within 48-72 hours, however, I was unable to return to work for 4 days and continue to experience a mild headache.
I had pain in my right arm and was diagnosis with frozen shoulder.  I have a reduced range of motion.  When I went to the doctor on 04/07/2021 I got a steroid shot in my shoulder. I had to have 4 weeks of physical therapy.
bubbly rash; itchy rash; red rash; delayed large pink rash at injection site (COVID Arm); injection site bleeding; injection site bruise; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (injection site bleeding), ADMINISTRATION SITE BRUISE (injection site bruise), RASH MACULAR (bubbly rash), RASH PRURITIC (itchy rash) and RASH ERYTHEMATOUS (red rash) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (injection site bleeding) and ADMINISTRATION SITE BRUISE (injection site bruise). On 20-Feb-2021, the patient experienced VACCINATION SITE RASH (delayed large pink rash at injection site (COVID Arm)). On an unknown date, the patient experienced RASH MACULAR (bubbly rash), RASH PRURITIC (itchy rash) and RASH ERYTHEMATOUS (red rash). At the time of the report, VACCINATION SITE HAEMORRHAGE (injection site bleeding), ADMINISTRATION SITE BRUISE (injection site bruise), RASH MACULAR (bubbly rash), RASH PRURITIC (itchy rash), RASH ERYTHEMATOUS (red rash) and VACCINATION SITE RASH (delayed large pink rash at injection site (COVID Arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Had a flush/rush in chest like water running through me about 5 minutes after receiving the vaccine. Then started to feel dizzy/weakness as if I was going to faint. I didn't tell the nurse on hand until 25 minutes later as I thought these were normal so I was asked to stay another 30 minutes after they took my pulse and BP. All was normal. But still felt weak. Stayed an hour then left.  Felt odd, not myself., out of sorts....went home, felt ok for an hour, then started feeling tired and fatigued...fell asleep and had diarrhea at night. Yesterday slept in, had one episode where I felt off and felt like I couldn't breath which lasted for a couple minutes. Feel ok today.
27 year old female comes in 3/27/21 at 4:15pm to get Pfizer COVID vaccine. She has no family doctor. On her VAR form she states no seizure or history of seizure but does have reaction to HPV vaccine where her throat swelled up and her MD had to give her oxygen year ago. I asked about any other reactions to any other vaccinations and she said no and was willing to get this vaccine.  I told her to wait 30 minutes after vaccination to make sure no reaction. At 4:25pm her sister and mom tell us that patient is feeling week and dizzy and ask for water, I go out and check and she is pale and is ready to faint. Mother asks for orange juice which she takes a sip. I ask her if she has any health conditions like diabetes, seizures and they say no, then patient has what looks like a petit mal (absence) seizure. While sitting in the chair her eyes flutter, roll back she tenses up and her body freezes for about 20-30 seconds. I tell staff to call 911 and her sister says she's having "another" seizure. We don't move her but make sure she doesn't fall, once the seizure passes we move her to the ground to lie down. She regains consciousness and is coherent but confused. I do not give EpiPen because I witnessed a seizure. The fire and ambulance arrive to assist her and then her family mentions she did have seizures years ago. After 20 minutes or around 4:50pm she feels better and does not want to go to the hospital and walks out assisted by fire/ambulance staff. The next day I call her and she says she feels better and just has a sore arm and will find new doctor check her out.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On 25-AUG-2014 the patient was vaccinated with a dose of VARIVAX (Merck) (dose, units, route of administration, lot# and expiration date were not reported) which was exposed to a supported temperature excursion on 15-AUG-2014. No adverse events had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
The first reaction was a pain in her neck, to the left of and at the base of her head. That went away within a day. She had a strange rash on the elbows and arms of both arms. These were minor problems. The issue that worried me and I spoke with her doctor about is her now constant diarrhea and indigestion. She has always been on the slightly constipated side. Now she is having a burning diarrhea that goes back and forth from being watery and a soft-serve consistency. Her indigestion is probably bothering her the most. Every time she eats, she has stomach acid regurgitate. She says it tastes like she's vomiting bits of her food into her mouth and it burns.
Eye tics (excessive eye blinking and squinting) started the next morning and haven't stopped.